Trial Profile
Efficacy of telaprevir (T) or boceprevir (B) based regimens HCV genotype 1 patients with end stage renal disease (ESRD) on dialysis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 09 Dec 2015 New trial record